S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

November 30, 1996

Primary Completion Date

December 31, 1998

Study Completion Date

July 31, 2000

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

recombinant interferon alfa

first 2 years

DRUG

dexamethasone

40 mg\*/d PO 1 - 4, 9 - 12, 17-20 q 35 days for 3 cycles\*

Trial Locations (40)

10021

Memorial Sloan-Kettering Cancer Center, New York

Weill Medical College of Cornell University, New York

10029

Mount Sinai Medical Center, NY, New York

11030

CCOP - North Shore University Hospital, Manhasset

North Shore University Hospital, Manhasset

13210

State University of New York - Upstate Medical University, Syracuse

Veterans Affairs Medical Center - Syracuse, Syracuse

13217

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse

14215

Veterans Affairs Medical Center - Buffalo, Buffalo

19899

CCOP - Christiana Care Health Services, Wilmington

20007

Lombardi Cancer Center, Washington D.C.

21201

Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

27705

Veterans Affairs Medical Center - Durham, Durham

27710

Duke Comprehensive Cancer Center, Durham

33140

CCOP - Mount Sinai Medical Center, Miami Beach

55417

Veterans Affairs Medical Center - Minneapolis, Minneapolis

55455

University of Minnesota Cancer Center, Minneapolis

60612

Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago

63110

Barnes-Jewish Hospital, St Louis

65201

Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia

65203

Ellis Fischel Cancer Center - Columbia, Columbia

89106

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas

94121

Veterans Affairs Medical Center - San Francisco, San Francisco

92093-0658

Rebecca and John Moores UCSD Cancer Center, La Jolla

20307-5000

Walter Reed Army Medical Center, Washington D.C.

60637-1470

University of Chicago Cancer Research Center, Chicago

52242-1009

Holden Comprehensive Cancer Center, Iowa City

02115

Dana-Farber Cancer Institute, Boston

01655

University of Massachusetts Memorial Medical Center - University Campus, Worcester

68198-7680

University of Nebraska Medical Center, Omaha

03756-0002

Norris Cotton Cancer Center, Lebanon

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27104-4241

CCOP - Southeast Cancer Control Consortium, Winston-Salem

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

02906

Lifespan: The Miriam Hospital, Providence

05401-3498

Vermont Cancer Center, Burlington

05009

Veterans Affairs Medical Center - White River Junction, White River Junction

23298-0037

MBCCOP - Massey Cancer Center, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Cancer and Leukemia Group B

NETWORK

lead

SWOG Cancer Research Network

NETWORK

NCT00002849 - S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis | Biotech Hunter | Biotech Hunter